Sign In
Buy RPRX
$53.57
+0.610 (+1.15%)
At Close: Jun 22, 2026
ChatGPT picks 5 stocks to buy for the start of 2025
05:00am, Wednesday, 25'th Dec 2024
As we enter the tail end of 2024, which has been a great year for the markets, as the S&P 500 has rallied by 27.35% since the beginning of the year, one question lies on the minds of investors the wor
3 High-Yield Dividend Stocks to Buy in 2025 and Hold for a Decade or Longer
04:30am, Friday, 13'th Dec 2024
The benchmark S&P 500 index keeps reaching new highs, but not all of its components have participated in the rally. Royalty Pharma (RPRX 0.04%), W.P.
2 Exceptional Dividend Stocks Near 52-Week Lows You Could Regret Not Buying on the Dips
05:37am, Wednesday, 04'th Dec 2024
The benchmark stock indexes keep climbing to new heights, but there are plenty of attractive wallflowers at this dance. A couple of overlooked dividend payers offer high yields and reliable dividend p
3 High-Yield Dividend Growth Stocks to Buy in December and Hold for a Decade or Longer
04:24am, Tuesday, 03'rd Dec 2024
It's been a great couple of years for the stock market. From the end of 2022 through Nov. 29, the benchmark S&P 500 (^GSPC 0.24%) index rose a whopping 57.1% higher.
Royalty Pharma to Present at Upcoming Investor Conferences
04:15pm, Wednesday, 27'th Nov 2024
NEW YORK, Nov. 27, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will participate in the following upcoming investor conferences during the month of December:
Undercovered Dozen: Aurora Cannabis, FREYR Battery, Royalty Pharma, Talos Energy +
08:00am, Saturday, 16'th Nov 2024
The 'Undercovered' Dozen series highlights 12 lesser-covered stocks from the past week, aiming to spark ideas and discussions among retail investors. Veradigm Inc. is undervalued due to regulatory pre
Royalty Pharma Announces Inaugural Prize for Impact in Healthcare
04:30pm, Thursday, 14'th Nov 2024
NEW YORK, Nov. 14, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced the inaugural Royalty Pharma Prize for Impact in Healthcare, which honors individuals or organizations who
3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade
05:20am, Thursday, 14'th Nov 2024
3 High-Yield Dividend Stocks You Can Buy With $130 Now and Hold at Least a Decade
Royalty Pharma: Massive Opportunity Ahead
12:46am, Saturday, 09'th Nov 2024
Royalty Pharma's Q3 results met expectations, with a modest 2024 outlook increase, driven by strong portfolio performance and new royalty acquisitions. The CF franchise remains a key cash cow despite
Royalty Pharma to Acquire Royalty Interest in Geron's RYTELO for $125 Million
07:10am, Thursday, 07'th Nov 2024
NEW YORK, Nov. 07, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today announced that it will acquire a synthetic royalty on U.S. sales of Geron Corporation's (Nasdaq: GERN) RYTELO for $1
Compared to Estimates, Royalty Pharma (RPRX) Q3 Earnings: A Look at Key Metrics
06:01pm, Wednesday, 06'th Nov 2024
The headline numbers for Royalty Pharma (RPRX) give insight into how the company performed in the quarter ended September 2024, but it may be worthwhile to compare some of its key metrics to Wall Stre
Royalty Pharma plc (RPRX) Q3 2024 Earnings Call Transcript
12:28pm, Wednesday, 06'th Nov 2024
Royalty Pharma plc (NASDAQ:RPRX ) Q3 2024 Earnings Conference Call November 6, 2024 8:30 AM ET Company Participants George Grofik - SVP, Head, Investor Relations and Communications Pablo Legorreta - F
Royalty Pharma (RPRX) Q3 Earnings and Revenues Surpass Estimates
09:35am, Wednesday, 06'th Nov 2024
Royalty Pharma (RPRX) came out with quarterly earnings of $1.04 per share, beating the Zacks Consensus Estimate of $0.95 per share. This compares to earnings of $0.79 per share a year ago.
Royalty Pharma Reports Third Quarter 2024 Results
07:15am, Wednesday, 06'th Nov 2024
NEW YORK, Nov. 06, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) today reported financial results for the third quarter of 2024 and raised full year 2024 guidance for Portfolio Receipts.
Royalty Pharma and Syndax Pharmaceuticals Enter Into $350 Million Royalty Funding Agreement for Niktimvo
04:15pm, Monday, 04'th Nov 2024
NEW YORK and WALTHAM, Mass., Nov. 04, 2024 (GLOBE NEWSWIRE) -- Royalty Pharma plc (Nasdaq: RPRX) and Syndax Pharmaceuticals (Nasdaq: SNDX) today announced that Royalty Pharma has entered into a $350 m
